Literature DB >> 9029406

Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin.

G A Gudelsky1.   

Abstract

The extent of long-term depletion of serotonin (5-HT) produced by 3,4-methylenedioxymethamphetmaine (MDMA) was assessed in rats treated with the antioxidants sodium ascorbate or L-cysteine. There was a 30-35% reduction in the striatal concentration of 5-HT 7 days following a single injection of MDMA (20 mg/kg, s.c.). MDMA had no significant effect on striatal concentrations of 5-HT in rats that had been treated with ascorbate (250 mg/kg, i.p.) or cysteine (500 mg/kg, i.p.) 30 min prior to and 5 hrs following the administration of MDMA. Treatment with ascorbate or cysteine did not alter the accumulation of MDMA in brain as determined by in vivo microdialysis. Moreover, neither ascorbate nor cysteine altered the stimulation of dopamine release elicited by MDMA. These data are supportive of the view that MDMA-induced toxicity of 5-HT neurons may be related to the production of free radicals and subsequent oxidative damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9029406     DOI: 10.1007/BF01271253

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  32 in total

Review 1.  The measurement and mechanism of lipid peroxidation in biological systems.

Authors:  J M Gutteridge; B Halliwell
Journal:  Trends Biochem Sci       Date:  1990-04       Impact factor: 13.807

2.  Methamphetamine-induced neuronal damage: a possible role for free radicals.

Authors:  M J De Vito; G C Wagner
Journal:  Neuropharmacology       Date:  1989-10       Impact factor: 5.250

3.  Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.

Authors:  G A Gudelsky; B K Yamamoto; J F Nash
Journal:  Eur J Pharmacol       Date:  1994-11-03       Impact factor: 4.432

4.  Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine.

Authors:  A Giovanni; L P Liang; T G Hastings; M J Zigmond
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

5.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Authors:  D L Commins; G Vosmer; R M Virus; W L Woolverton; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

6.  5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.

Authors:  C J Schmidt; V L Taylor; G M Abbate; T R Nieduzak
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

7.  MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

Authors:  G Battaglia; S Y Yeh; E B De Souza
Journal:  Pharmacol Biochem Behav       Date:  1988-02       Impact factor: 3.533

8.  The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.

Authors:  J E Sprague; D E Nichols
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

9.  Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.

Authors:  C J Schmidt; C K Sullivan; G M Fadayel
Journal:  J Neurochem       Date:  1994-04       Impact factor: 5.372

10.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

Authors:  C J Schmidt
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

View more
  13 in total

Review 1.  Causes and consequences of methamphetamine and MDMA toxicity.

Authors:  Maria S Quinton; Bryan K Yamamoto
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

2.  Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes.

Authors:  Sylvia K Shenouda; Kurt J Varner; Felix Carvalho; Pamela A Lucchesi
Journal:  Cardiovasc Toxicol       Date:  2009-03-31       Impact factor: 3.231

3.  Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons.

Authors:  D M Kuhn; R Arthur
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

Review 4.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake.

Authors:  Courtney Huff; Nirmal Bhide; Allen Schroering; Bryan K Yamamoto; Gary A Gudelsky
Journal:  Brain Res Bull       Date:  2013-01-12       Impact factor: 4.077

Review 6.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

Review 7.  Developmental effects of 3,4-methylenedioxymethamphetamine: a review.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

Review 8.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

9.  Ecstasy produces left ventricular dysfunction and oxidative stress in rats.

Authors:  Sylvia K Shenouda; Kevin C Lord; Elizabeth McIlwain; Pamela A Lucchesi; Kurt J Varner
Journal:  Cardiovasc Res       Date:  2008-05-20       Impact factor: 10.787

Review 10.  Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Laura E Halpin; Stuart A Collins; Bryan K Yamamoto
Journal:  Life Sci       Date:  2013-07-24       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.